Literature DB >> 18000718

Metabolic and nutritional status changes after 10% weight loss in severely obese patients treated with laparoscopic surgery vs integrated medical treatment.

Federica del Genio1, Lucia Alfonsi, Maurizio Marra, Carmine Finelli, Gianmattia del Genio, Gianluca Rossetti, Alberto del Genio, Franco Contaldo, Fabrizio Pasanisi.   

Abstract

BACKGROUND: Bariatric surgery is considered the most effective treatment for reducing excess body weight and maintaining weight loss (WL) in severely obese patients. There are limited data evaluating metabolic and body composition changes after different treatments in type III obese (body mass index [BMI] > 40 kg/m(2)).
METHODS: Twenty patients (9 males, 11 females; 37.6 +/- 8 years; BMI = 50.1 +/- 8 kg/m(2)) treated with dietary therapy and lifestyle correction (group 1) have been compared with 20 matched patients (41.8 +/- 6 years; BMI = 50.4 +/- 6 kg/m(2)) treated with laparoscopic gastric bypass (LGBP; group 2). Patients have been evaluated before treatment and after >10% WL obtained on average 6 weeks after LGBP and 30 weeks after integrated medical treatment. Metabolic syndrome (MS) was evaluated using the Adult Treatment Panel III/America Heart Association (ATP III/AHA) criteria. Resting metabolic rate (RMR) and respiratory quotient (RQ) was assessed with indirect calorimetry; body composition with bioimpedance analysis.
RESULTS: At entry, RMR/fat-free mass (FFM) was 34.2 +/- 7 kcal/24 h.kg in group 1 and 35.1 +/- 8 kcal/24 h.kg in group 2 and did not decrease in both groups after 10% WL (31.8 +/- 6 vs 34.0 +/- 6). Percent FFM and fat mass (FM) was 50.7 +/- 7% and 49.3 +/- 7% in group 1 and 52.1 +/- 6% and 47.9 +/- 6% in group 2, respectively (p = n.s.). After WL, body composition significantly changed only in group 1 (% FFM increased to 55.9 +/- 6 and % FM decreased to 44.1 +/- 6; p = 0.002).
CONCLUSION: After >10% WL, MS prevalence decreases precociously in surgically treated patients; some improvements in body composition are observed in nonsurgically treated patients only. Further investigations are needed to evaluate long-term effects of bariatric surgery on body composition and RMR after stable WL.

Entities:  

Mesh:

Year:  2007        PMID: 18000718     DOI: 10.1007/s11695-007-9286-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  40 in total

1.  Meta-analysis of resting metabolic rate in formerly obese subjects.

Authors:  A Astrup; P C Gøtzsche; K van de Werken; C Ranneries; S Toubro; A Raben; B Buemann
Journal:  Am J Clin Nutr       Date:  1999-06       Impact factor: 7.045

Review 2.  Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice.

Authors:  J D Douketis; C Macie; L Thabane; D F Williamson
Journal:  Int J Obes (Lond)       Date:  2005-10       Impact factor: 5.095

3.  Body composition and metabolic changes following bariatric surgery: effects on fat mass, lean mass and basal metabolic rate: six months to one-year follow-up.

Authors:  Daniel Gene Carey; German J Pliego; Robert L Raymond
Journal:  Obes Surg       Date:  2006-12       Impact factor: 4.129

4.  Laparoscopic gastric banding and body composition in morbid obesity.

Authors:  Bruna Guida; Anna Belfiore; Luigi Angrisani; Fausta Micanti; Concetta Mauriello; Rossella Trio; Pierluigi Pecoraro; Claudio Falconi
Journal:  Nutr Metab Cardiovasc Dis       Date:  2005-06       Impact factor: 4.222

5.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

6.  Bariatric surgery worldwide 2003.

Authors:  Henry Buchwald; Stanley E Williams
Journal:  Obes Surg       Date:  2004-10       Impact factor: 4.129

7.  Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis.

Authors:  A M Dattilo; P M Kris-Etherton
Journal:  Am J Clin Nutr       Date:  1992-08       Impact factor: 7.045

8.  The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.

Authors:  Francesco Rubino; Michel Gagner; Paolo Gentileschi; Subhash Kini; Shoji Fukuyama; John Feng; Ed Diamond
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

9.  Effect of modest weight loss on changes in cardiovascular risk factors: are there differences between men and women or between weight loss and maintenance?

Authors:  R R Wing; R W Jeffery
Journal:  Int J Obes Relat Metab Disord       Date:  1995-01

10.  Body composition and energy expenditure: relationship and changes in obese subjects before and after biliopancreatic diversion.

Authors:  Roberto M Tacchino; Antonio Mancini; Michele Perrelli; Antonio Bianchi; Antonella Giampietro; Domenico Milardi; Chiara Vezzosi; Eugenia Sacco; Laura De Marinis
Journal:  Metabolism       Date:  2003-05       Impact factor: 8.694

View more
  15 in total

1.  Endoscopic cervical bariatric surgery: follow-up study in a porcine model.

Authors:  Gianmattia del Genio; Michel Gagner; David Nocca; Federico Cuenca-Abente; Laurent Biertho; Anne Waage; Barbara Faife; Federica del Genio; Camilo Boza; Rajesh Aggarwal; Alberto Del Genio
Journal:  Obes Surg       Date:  2008-05-28       Impact factor: 4.129

2.  Laparoscopic sleeve gastrectomy with duodeno-jejunal bypass: a new surgical procedure for weight control. Feasibility and safety study in a porcine model.

Authors:  Gianmattia Del Genio; Michel Gagner; Federico Cuenca-Abente; David Nocca; Laurent Biertho; Federica Del Genio; Ahmad Assalia; Alberto Del Genio
Journal:  Obes Surg       Date:  2008-06-18       Impact factor: 4.129

3.  Noninvasive evaluation of abdominal fat and liver changes following progressive weight loss in severely obese patients treated with laparoscopic gastric bypass.

Authors:  Federica Del Genio; Gianmattia Del Genio; Ilario De Sio; Maurizio Marra; Lucia Alfonsi; Carmine Finelli; Franco Contaldo; Fabrizio Pasanisi
Journal:  Obes Surg       Date:  2009-12       Impact factor: 4.129

Review 4.  Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?

Authors:  Carmine Finelli; Maria Carmela Padula; Giuseppe Martelli; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

5.  Stability of Metabolic Factor Before and After Bariatric Surgery.

Authors:  Brandon Davis; Joseph Indelicato
Journal:  Obes Surg       Date:  2016-10       Impact factor: 4.129

6.  Vagal innervation of the hepatic portal vein and liver is not necessary for Roux-en-Y gastric bypass surgery-induced hypophagia, weight loss, and hypermetabolism.

Authors:  Andrew C Shin; Huiyuan Zheng; Hans-Rudolf Berthoud
Journal:  Ann Surg       Date:  2012-02       Impact factor: 12.969

7.  Dietetic-led management of patients undergoing laparoscopic gastric banding: early results.

Authors:  Rishi Singhal; Mark Kitchen; Sue Bridgwater; Paul Super
Journal:  Surg Endosc       Date:  2009-12-09       Impact factor: 4.584

Review 8.  Obesity surgery and gut-brain communication.

Authors:  Hans-Rudolf Berthoud; Andrew C Shin; Huiyuan Zheng
Journal:  Physiol Behav       Date:  2011-02-24

9.  Effects of RYGB on energy expenditure, appetite and glycaemic control: a randomized controlled clinical trial.

Authors:  J B Schmidt; S D Pedersen; N T Gregersen; L Vestergaard; M S Nielsen; C Ritz; S Madsbad; D Worm; D L Hansen; T R Clausen; J F Rehfeld; A Astrup; J J Holst; A Sjödin
Journal:  Int J Obes (Lond)       Date:  2013-08-25       Impact factor: 5.095

10.  Effects of alternate fasting or very low calorie diet and low calorie diet on metabolic syndrome in severely obese patients.

Authors:  M Tančić-Gajić; S Vujović; M Vukčević; M Ivović; M Drezgić; Lv Marina; M Stojanović; Z Arizanović; A Nenezić; D Micić
Journal:  Hippokratia       Date:  2012-10       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.